These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 30350208)

  • 1. Gene Disruption Using CRISPR-Cas9 Technology.
    Hu N; Malek SN
    Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
    Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
    He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
    Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-Based Gene Dropout Screens.
    Wu K; Malek SN
    Methods Mol Biol; 2019; 1881():185-200. PubMed ID: 30350207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
    Bloomer H; Smith RH; Hakami W; Larochelle A
    Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
    Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
    Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites.
    Dabrowska M; Czubak K; Juzwa W; Krzyzosiak WJ; Olejniczak M; Kozlowski P
    Nucleic Acids Res; 2018 Sep; 46(17):e101. PubMed ID: 29878242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
    Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
    Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation.
    Xu X; Gao D; Wang P; Chen J; Ruan J; Xu J; Xia X
    Sci Rep; 2018 Aug; 8(1):11649. PubMed ID: 30076383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Microbial Modification Tools to Convert Lipids into Other Value-Added Products.
    Kumari P; Yusuf F; Gaur NA
    Methods Mol Biol; 2019; 1995():161-171. PubMed ID: 31148128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finally, Archaea Get Their CRISPR-Cas Toolbox.
    Gophna U; Allers T; Marchfelder A
    Trends Microbiol; 2017 Jun; 25(6):430-432. PubMed ID: 28391963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing.
    Fu YW; Dai XY; Wang WT; Yang ZX; Zhao JJ; Zhang JP; Wen W; Zhang F; Oberg KC; Zhang L; Cheng T; Zhang XB
    Nucleic Acids Res; 2021 Jan; 49(2):969-985. PubMed ID: 33398341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair.
    Savic N; Ringnalda FC; Lindsay H; Berk C; Bargsten K; Li Y; Neri D; Robinson MD; Ciaudo C; Hall J; Jinek M; Schwank G
    Elife; 2018 May; 7():. PubMed ID: 29809142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR as a strong gene editing tool.
    Shen S; Loh TJ; Shen H; Zheng X; Shen H
    BMB Rep; 2017 Jan; 50(1):20-24. PubMed ID: 27616359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.